difference between semaglutide or tirzepatide and key differences, weight loss results (2026) 👉 Which treatment is right

The study completed in November 2024 demonstrating statistically significant efficacy with UC clinical remission rates of 36% (450mg) and 48% (900mg) versus 20% placebo, favorable safety profile with lower adverse event rates than placebo, and led to a long-term extension study (NCT05668013) providing 44-week maintenance therapy for responders and re-induction for non-responders to evaluate sustained efficacy and corticosteroid-free remission (77, 78)

In addition, injections may be especially beneficial in individuals with gastrointestinal absorption issues

Your basal metabolic rate may drop by 510% during recovery as your body prioritizes immune healing over energy expenditure

The food gap and caffeine cutoff are free and produce the fastest results

Within the same formulations, the probabilities of experiencing serious and non-serious adverse drug reactions (ADEs) are roughly similar

Clinical studies show average weight loss of 12-15 pounds in weeks 5-12